Table 1

Clinico-pathological and demographic patient characteristics

Imaging only (n=2207)PaLND
(n=333)
P value
Age (years)
<50
 >50
1470 (45.8%)
1737 (54.2%)
209 (62.8%)
124 (37.2%)
<0.001
Race
 White
 Other/Unknown
2438 (76%)
769 (24%)
251 (75.4%)
82 (24.6%)
0.79
Comorbidities
 No
 Yes
2706 (84.4%)
501 (15.6%)
304 (91.3%)
29 (8.7%)
<0.001
Insurance
 Private
 Government
 Uninsured/Unknown
1211 (37.8%)
1569 (48.9%)
427 (13.3%)
163 (48.9%)
129 (38.7%)
41 (12.4%)
<0.001
Year of diagnosis
 2010–2012
 2013–2015
1360 (42.4%)
1847 (57.6%)
174 (52.3%)
159 (47.7%)
<0.001
Histology
 Squamous
 Adenocarcinoma
 Adenosquamous
2706 (84.4%)
431 (13.4%)
70 (2.2%)
286 (85.9%)
34 (10.2%)
13 (3.9%)
0.043
Stage
 IB2-II
 III-IVA
1721 (53.7%)
1486 (46.3%)
179 (53.8%)
154 (46.2%)
0.98
Vaginal brachytherapy
 No
 Yes
933 (29.1%)
2274 (70.9%)
77 (23.1%)
256 (76.9%)
0.022
Travel distance (miles)*
 <12.5
 12.5–49.9
>50
1722 (53.8%)
1038 (32.4%)
443 (13.8%)
172 (51.7%)
112 (33.6%)
49 (14.7%)
0.76
  • *missing for 4 cases.

  • PaLND, para-aortic lymphadenectomy.